Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-09-30 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
P | Common Stock | A | 23836 | $0.23 - $3.43 | $11,308 |
2024-05-28 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
P | Common Stock | A | 15000 | $0.52 - $0.52 | $7,774 |
2024-05-21 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
P | Common Stock | A | 50000 | $0.58 - $0.64 | $30,474 |
2024-05-10 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
P | Common Stock | A | 40000 | $0.47 - $0.49 | $18,865 |
2024-05-07 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
P | Common Stock | A | 66300 | $0.37 - $0.37 | $24,816 |
2024-05-06 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
P | Common Stock | A | 135000 | $0.38 - $0.38 | $50,665 |
2024-07-19 | BRAINSTORM CELL THERAPEUTICS INC. | Dagher Ibrahim B.
(Chief Medical Officer) |
S | Common Stock | D | 63000 | $0.35 - $0.35 | $22,068 |
2024-06-24 | BRAINSTORM CELL THERAPEUTICS INC. | HARTOUNIAN HARTOUN
(EVP, Chief Operating Officer) |
A | Common Stock | A | 30000 | $0.00 - $0.00 | $0 |
2024-05-28 | BRAINSTORM CELL THERAPEUTICS INC. | Lebovits Chaim
(President & CEO) |
A | Common Stock | A | 15000 | $0.52 - $0.52 | $7,774 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |